Introduction:
Imaging tests are ways to show doctors what is happening inside the body. These tests send a form of energy (X-rays, sound waves, radioactive particles, magnetic fields) through the body. The tissues of the body change energy patterns to create pictures and images. These images show what the inside looks and functions like so that healthcare providers can see the changes that diseases such as cancer can cause. Imaging tests are often very helpful, but they have limitations. For example, these tests alone cannot, in most cases, reliably determine whether changes are caused by cancer.
Imaging tests can find large clusters of cancer cells, but imaging tests cannot show a single cancer cell or a few cancer cells. In fact, it takes millions of cells to make a tumor big enough to be visible on imaging tests. Therefore, treatment can be continued even if cancer cells cannot be seen on imaging tests. The goal is to save surviving cancer cells. Even one can grow and become a tumor over time, becoming large enough to cause problems or show up on imaging tests.
What Are the Uses of Radiological Imaging in Cancer Diagnosis and Treatment?
The uses of radiological imaging in cancer diagnosis and treatment are listed below:
-
It may be used to look for cancer in the early stages (small, non-metastatic stages) of cancer and may not have symptoms. This is sometimes called an early detection or cancer screening test.
-
It can be used to look for lumps or lumps (tumors) when people have symptoms. It can also help find out if the symptoms are caused by cancer or another type of disease.
-
It can help predict whether a tumor may be cancer. This will help the healthcare provider decide if a biopsy is needed. (A small piece of tissue is removed and seen under a microscope). A biopsy is usually needed to confirm that the lesion is cancerous.
-
It can show where tumors are located, and even deeper into the body. This will help if a biopsy is needed.
-
It helps determine the stage of cancer (to find out if and how far the cancer has spread).
-
It can be used for treatment planning. To indicate where the radiotherapy beam should be focused.
-
It can indicate whether a tumor has shrunk, stayed the same, or grown after treatment. This allows the cancer care team to know how well the treatment is working.
-
It can help find out if the cancer has come back after it has been treated.
What Is a PET/CT Scan?
A positron emission tomography (PET) scan is an imaging test that helps reveal the metabolic or biochemical function of tissues and organs. PET scans use radioactive agents called tracers to show both typical and atypical metabolic activity. PET scans can detect atypical metabolism of tracers in disease, often before disease manifests itself on other imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI).
The tracer is usually injected into a vein in the hand or arm. The tracer then accumulates in areas of the body with high levels of metabolic or biochemical activity. This often marks the location of the disease. A PET image is usually combined with a CT or MRI and is called a PET/CT or PET/MRI scan.
What Is Prostate Cancer?
The prostate gland is an accessory gland present in the male reproductive system and also helps in switching between ejaculation and urination. Prostate cancer is a disease in which malignant (cancerous cells that spread to other parts of the body) cells develop in the tissues of the prostate gland. Symptoms of prostate cancer are poor urine flow and frequent urination.
What Is the Role of PET/CT in Prostate Cancer Assessment?
PET scans are done in the case of prostate cancer due to their ability to target and acquire images of cellular levels of prostate cancer. This will enable more accurate staging and restaging across prostate cancer treatment strategies. PET scans continue to lead the imaging potential during prostate cancer treatment as new radiotracers are developed and studied.
PET scanning has revolutionized how prostate cancer is imaged because it can target cancer at the cellular and molecular levels. A PET scan involves the use of a radioactive tracer that is absorbed and visualized by cancer cells related to the prostate. This makes PET scans an excellent alternative to traditional imaging modalities that assess only an anatomical 'snapshot' of abnormalities rather than the functional aspects of the PET scan.
A PET scan works in combination with a CT scan taken simultaneously. Because CT captures high-quality anatomical images and PET detects changes at the molecular level, the combination of the two produces highly accurate superimposed single images that other imaging modalities cannot reproduce. PET scans are often the first choice in determining the clearest path of diagnosis for many prostate cancer patients. Specifically, it is now used primarily for men with suspected recurrence of prostate cancer after treatment. can be detected and characterized.
When Are PET/CT Scans Used for Prostate Cancer?
PET/CT scan is used for prostate cancer in the following cases:
-
Staging - PET scans are used in patients with known prostate cancer to pinpoint its exact location, determine the stage of the disease, and determine the strategies for treatment.
-
Treatment Plan - In some cases, PET scans can be used to target specific high-risk areas for specific treatments. Hidden areas of cancer spread can be detected with the help of a PET scan.
-
Evaluation During and After Treatment - PET scans can be used during and after prostate cancer treatment to determine the effectiveness and response of certain drugs and treatments.
-
Ongoing Cancer Treatment With Recurrent Prostate Cancer - A PET scan allows doctors to identify and evaluate the extent of recurrent prostate cancer. A new radiopharmaceutical known as Axumin is able to detect recurrent prostate cancer, even in patients with early stages and low prostate-specific antigen (PSA) levels.
What Are the Types of PET Scans for Prostate Cancer?
The types of PET scans used in case of prostate cancer are listed below:
-
Prostate Specific Membrane Antigen (PSMA) PET scan - It is currently FDA-approved and used for prostate cancer localization, staging, and staging. PSMA PET scans are Food and Drug Association (FDA) approved for use after prostate cancer has been diagnosed to determine if the cancer has spread to other parts of the body. It is also approved to localize and reassess recurrent prostate cancer in patients with biochemical recurrence.
-
Axmin (Fluciclovine F-18) PET Scan - It is currently used primarily for restaging recurrent prostate cancer in patients with suspected biochemical recurrence.
-
FDG (Fluorodeoxyglucose) PET Scan - It can also be used for staging certain cases of prostate cancer. In some cases, FDG PET scans can also be used to reclassify recurrent prostate cancer, depending on the prostate cancer tumor type.
Conclusion:
Prostate cancer is one of the most common cancers in men. New PET imaging with prostate-specific membrane antigen (PSMA) will significantly improve the detection and treatment of prostate cancer. PET/CT has emerged as a promising staging method for primary and recurrent prostate cancer. New tracers have improved accuracy in detecting small early metastatic lesions. The clinical significance of these potential PET/CT-detected foci requires systematic evaluation. Efforts should aim to define their natural history and response and efficacy of metastatic therapy.
